[go: up one dir, main page]

MX2019002422A - Proteina sin fenilalanina para el tratamiento de pku. - Google Patents

Proteina sin fenilalanina para el tratamiento de pku.

Info

Publication number
MX2019002422A
MX2019002422A MX2019002422A MX2019002422A MX2019002422A MX 2019002422 A MX2019002422 A MX 2019002422A MX 2019002422 A MX2019002422 A MX 2019002422A MX 2019002422 A MX2019002422 A MX 2019002422A MX 2019002422 A MX2019002422 A MX 2019002422A
Authority
MX
Mexico
Prior art keywords
protein
phenylalanine
dietary
pku
treatment
Prior art date
Application number
MX2019002422A
Other languages
English (en)
Other versions
MX378970B (es
Inventor
Hoffmann Bernhard
Mücke Yvonne
Rasche Stefan
Jablonka Natalia
Schillberg Stefan
Original Assignee
Metax Inst Fuer Diaetetik Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Metax Inst Fuer Diaetetik Gmbh filed Critical Metax Inst Fuer Diaetetik Gmbh
Publication of MX2019002422A publication Critical patent/MX2019002422A/es
Publication of MX378970B publication Critical patent/MX378970B/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/32Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/195Proteins from microorganisms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00Food ingredients
    • A23V2250/54Proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/20Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/21Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Soy Sauces And Products Related Thereto (AREA)

Abstract

Se proporciona una proteína dietética recombinante que está libre de fenilalanina y es una proteína dietética con un alto valor biológico. Se proporcionan además un vector que codifica para la proteína dietética, microorganismos que expresan la proteína, un método para la producción de la proteína y una composición dietética que comprende la proteína que en una modalidad es para usarse como un medicamento y/o alimento para propósitos médicos especiales en pacientes con acumulaciones de fenilalanina en el cuerpo.
MX2019002422A 2016-09-01 2017-08-30 Proteína sin fenilalanina para el tratamiento de pku. MX378970B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16186895.5A EP3290436B1 (en) 2016-09-01 2016-09-01 Phenylalanine-free protein for the treatment of pku
PCT/EP2017/071814 WO2018041920A1 (en) 2016-09-01 2017-08-30 Phenylalanine-free protein for the treatment of pku

Publications (2)

Publication Number Publication Date
MX2019002422A true MX2019002422A (es) 2019-07-04
MX378970B MX378970B (es) 2025-03-10

Family

ID=56883591

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019002422A MX378970B (es) 2016-09-01 2017-08-30 Proteína sin fenilalanina para el tratamiento de pku.

Country Status (28)

Country Link
US (1) US10640538B2 (es)
EP (1) EP3290436B1 (es)
JP (1) JP6954676B2 (es)
CN (1) CN109661401B (es)
AU (1) AU2017317652B2 (es)
BR (1) BR112019004270A2 (es)
CA (1) CA3033271C (es)
CY (1) CY1121886T1 (es)
DK (1) DK3290436T3 (es)
ES (1) ES2742175T3 (es)
HR (1) HRP20191406T1 (es)
HU (1) HUE044665T2 (es)
IL (1) IL265015B2 (es)
LT (1) LT3290436T (es)
MA (1) MA43352B1 (es)
MD (1) MD3290436T2 (es)
ME (1) ME03510B (es)
MX (1) MX378970B (es)
NZ (1) NZ750498A (es)
PL (1) PL3290436T3 (es)
PT (1) PT3290436T (es)
RU (1) RU2764796C2 (es)
SA (1) SA519401175B1 (es)
SI (1) SI3290436T1 (es)
SM (1) SMT201900464T1 (es)
UA (1) UA124630C2 (es)
WO (1) WO2018041920A1 (es)
ZA (1) ZA201901505B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110747218A (zh) * 2019-09-27 2020-02-04 深圳市诺维健生物技术有限责任公司 一种特殊膳食蛋白质的生产方法与应用
CN113264988B (zh) * 2019-09-27 2022-12-06 湖北康肽药业有限公司 一组特殊膳食蛋白质

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04126051A (ja) * 1990-09-18 1992-04-27 Snow Brand Milk Prod Co Ltd フェニルケトン尿症患者用栄養調製物
GB9310472D0 (en) 1993-05-20 1993-07-07 Univ Warwick Phenylalanine-free protein and dna coding thereof
GB9314802D0 (en) * 1993-07-16 1993-08-25 Pharmaceutical Proteins Ltd Modified proteins
WO1996017064A1 (en) 1994-12-02 1996-06-06 Indiana University Foundation Phenylalanine free proteins
EP1092769B1 (de) * 1999-10-15 2008-10-29 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Polypeptid-Tag's für den Nachweis und die Aufreinigung von Polypeptiden
ATE386110T1 (de) * 2000-12-07 2008-03-15 Dsm Ip Assets Bv Prolylendoprotease aus aspergillus niger
US9034402B2 (en) * 2007-04-16 2015-05-19 Solae, Llc Protein hydrolysate compositions having improved sensory characteristics and physical properties
WO2008134461A2 (en) 2007-04-27 2008-11-06 Dow Global Technologies, Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
WO2010124180A1 (en) * 2009-04-23 2010-10-28 Phasebio Pharmaceuticals, Inc. Phenylalanine hydroxylase fusion protein and methods for treating phenylketonuria
WO2013133691A1 (en) * 2012-03-09 2013-09-12 N.V. Nutricia Liquid nutritional composition comprising free amino acids
WO2013148332A1 (en) 2012-03-26 2013-10-03 Pronutria, Inc. Nutritive fragments and proteins with low or no phenylalanine and methods
CN104936466A (zh) 2012-11-20 2015-09-23 普罗努塔利亚公司 工程化的分泌蛋白质和方法
PL3197472T3 (pl) 2014-09-22 2021-12-27 Tanea Medical Ab Rekombinowane białka wolne od phe do stosowania w leczeniu fenyloketonurii

Also Published As

Publication number Publication date
RU2019109142A3 (es) 2021-01-27
MD3290436T2 (ro) 2019-10-31
ME03510B (me) 2020-04-20
RU2764796C2 (ru) 2022-01-21
LT3290436T (lt) 2019-10-10
CN109661401B (zh) 2023-12-19
AU2017317652B2 (en) 2020-11-19
DK3290436T3 (da) 2019-08-19
HRP20191406T1 (hr) 2019-11-15
SA519401175B1 (ar) 2022-01-08
US20190202872A1 (en) 2019-07-04
CA3033271A1 (en) 2018-03-08
UA124630C2 (uk) 2021-10-20
PL3290436T3 (pl) 2020-01-31
RU2019109142A (ru) 2020-10-01
IL265015B1 (en) 2024-04-01
SMT201900464T1 (it) 2020-01-14
EP3290436B1 (en) 2019-06-05
IL265015A (es) 2019-04-30
MA43352A (fr) 2018-03-07
NZ750498A (en) 2023-01-27
ES2742175T3 (es) 2020-02-13
HUE044665T2 (hu) 2019-11-28
CA3033271C (en) 2024-04-02
PT3290436T (pt) 2019-08-30
CN109661401A (zh) 2019-04-19
JP6954676B2 (ja) 2021-10-27
JP2019533988A (ja) 2019-11-28
SI3290436T1 (sl) 2019-11-29
ZA201901505B (en) 2020-08-26
US10640538B2 (en) 2020-05-05
EP3290436A1 (en) 2018-03-07
MX378970B (es) 2025-03-10
CY1121886T1 (el) 2020-10-14
IL265015B2 (en) 2024-08-01
MA43352B1 (fr) 2019-08-30
WO2018041920A1 (en) 2018-03-08
AU2017317652A1 (en) 2019-02-28
BR112019004270A2 (pt) 2019-06-04

Similar Documents

Publication Publication Date Title
CO2018004564A2 (es) Genes de ataxia de friedreich modificados y vectores para terapia génica
MX2018002990A (es) Uso de la akkermansia pasteurizada para tratar trastornos metabolicos.
GEP20217326B (en) Constructs having a sirp-alpha domain or variant thereof
EP4631970A3 (en) Nucleic acid molecules and uses thereof
AU367093S (en) Medical injector
AU367108S (en) Medical injector
CO2020004158A2 (es) Composición de proteínas de guisante que tiene calidad nutricional mejorada
AU201615371S (en) Patient interface
MX2018005315A (es) Composiciones y metodos para el tratamiento del cancer.
UY34346A (es) Proteínas de fusión para tratar trastornos metabólicos
ZA201700196B (en) Methods for treating high cardiovascular risk patients with hypercholesterolemia
MX2018002546A (es) Composiciones que comprenden un compuesto de urolitina.
AU367237S (en) Inhaler
PE20171076A1 (es) Composicion que contiene quitina y proteinas digeribles
AU201714797S (en) Bottle
MX379359B (es) Derivados de 8-amino-2-oxo-1,3-diaza-espiro-[4.5]-decano.
AU364719S (en) Medicine inhaler
MX2018008640A (es) Derivados de 3-(carboxietil)-8-amino-2-oxo-1,3-diaza-espiro-[4.5]- decano.
PE20151866A1 (es) Composiciones nutricionales que contienen un componente peptidico con propiedades estimulantes de adiponectina y usos del mismo
AU201615567S (en) Invalid chair
MX2017015293A (es) Composicion para tratar lesiones tisulares.
AU201617166S (en) Cannula pad
MX2019002422A (es) Proteina sin fenilalanina para el tratamiento de pku.
BR112019005959A2 (pt) gene dgkk recombinante para terapia genética da síndrome do x frágil
PH12016502284B1 (en) Cough medicine containing ambroxol hydrochloride